Christina Farr

Christina Farr is a healthcare writer and investor. Formerly at CNBC and Reuters, she covers digital health, startups, and policy, blending reporting with analysis and investing perspective to help leaders navigate healthcare’s evolving landscape.

New York City · 261 posts

Markets

OMG! Omada Health just filed its S1.

Christina Farr May 9, 2025 3 min read

Omada got its start in 2011.

Podcast

How dietary guidelines changed our rate of aging with Stephanie Venn-Watson

Christina Farr May 7, 2025

This week on Second Opinion, Christina Farr and Ash Zenooz interview Seraphina Therapeutics CEO Steph Venn-Watson, unpacking why men dominate the longevity space, the cellular secrets of aging, and C15:0’s potential to boost health.

Markets

Some tough questions VCs and founders need to address out in the open

Christina Farr May 5, 2025 11 min read

What are the hidden trade offs of fund size. When should founders be able to take money off the table?

Podcast

The healthcare check-in: HES, tariffs, AI and more

Christina Farr April 16, 2025

In this episode of Second Opinion, hosts Christina Farr, Ash Zenooz, and Luba Greenwood discuss the latest trends in healthcare, including conferences, the economic impact on health tech and biotech sectors, the potential for AI to reduce administrative burdens, and the dynamics of the IPO market.